$Unity Biotechnology(UBX)$So far, that seems to be the case.Recent studies in micehave shown that eliminating senescent cells have improved life spans and the overall health of the subjects. This underscores the firm’s novel approach.
For investors, Unity could be a blockbuster long-term play as the firm moves into real testing of itssenolytic therapies. There’s risk here and the IPO was used to raise cash for discovery. But the long-term potential is there.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments